Publications
126
Citations
5,467
Est. group size
—
Recurring co-author estimate
Active years
52
Publishing since 1975
Typically publishes in teams of ~11 · 3% small-team papers (≤3 authors) · across 33 venues
- VEGFR1-Blocking Antibody Improves Endothelial Structure, Kidney Function, and GFR in Diabetic Mice
Journal of the American Society of Nephrology · 2026
- A validated multivariable machine learning model to predict cardio-kidney risk in diabetic kidney disease
Cardiovascular Diabetology · 2025
- Rapid on-chip nucleic acid extraction for point-of-care salivary diagnostics
Analytical Methods · 2025
- Size Reduction Southward in Michigan's Mustard White Butterfly, Pieris Napi (Lepidoptera: Pieridae)
The Great Lakes Entomologist · 2025
- Portable, Isothermal Amplification and Detection of High-Risk Human Papillomavirus
SSRN Electronic Journal · 2025
- Predictive Value of Established and Novel Biomarkers for Kidney Outcomes in CKD: A Comparative Validation Study
Journal of the American Society of Nephrology · 2025
- The fibroblast hormone Endotrophin is a biomarker of mortality in chronic diseases
Matrix Biology · 2024
- Natriuretic Peptides and Prognosis in Patients With Type 2 Diabetes Mellitus and High Risk for Cardiovascular Events
Journal of Cardiac Failure · 2024
- Canagliflozin and iron metabolism in the CREDENCE trial
Nephrology Dialysis Transplantation · 2024
- Multi-omics subgroups associated with glycaemic deterioration in type 2 diabetes: an IMI-RHAPSODY Study
Frontiers in Endocrinology · 2024
- Vascular endothelial growth factors and risk of cardio-renal events: Results from the CREDENCE trial
American Heart Journal · 2024
- Assessing Heterogeneity of Treatment Effects from Canagliflozin (CANA) on Kidney Outcomes Using the Joslin Kidney Panel: Insights from the CREDENCE Trial
Journal of the American Society of Nephrology · 2024
- Fasting substrates predict chronic kidney disease progression in CREDENCE trial patients with type 2 diabetes
JCI Insight · 2024
- Identification of biomarkers for glycaemic deterioration in type 2 diabetes
Nature Communications · 2023
- Cardiorenal Biomarkers, Canagliflozin, and Outcomes in Diabetic Kidney Disease: The CREDENCE Trial
Circulation · 2023
- Diabetes×13
- Journal of the American Society of Nephrology×9
- Diabetes Care×4
- Cardiovascular Diabetology×4
- Diabetologia×3
- Swayam Prakash Srivastava
Medicine · University of Michigan
- Richard D. DiMarchi
Medicine · Indiana University
- David T. Broome
Medicine · University of Michigan
- Kieren J. Mather
Medicine · Indiana University
- Eugênio Cersósimo
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile